Lyudmila Bazhenova

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Neuvogen
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Intervenn
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Elevation Oncology
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    ORIC
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Novocure
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    regeneron
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Mirati
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Turning point
    Topic: 
    lung cancer
    Date added: 
    08/12/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Daichi
    Topic: 
    lung cancer
    Date added: 
    08/12/2022

Pages

Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference